SOLUBILIZED MAGNOLOL ANALOGS
    34.
    发明公开
    SOLUBILIZED MAGNOLOL ANALOGS 有权
    增溶MAGNOLOL类似物

    公开(公告)号:EP2790645A1

    公开(公告)日:2014-10-22

    申请号:EP11806077.1

    申请日:2011-12-15

    Abstract: A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol and a sorbitan ester. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti -bacterial activity and reducing the expression of pro - inflammatory mediators. If isopropyl is selected, then the sorbitan ester is at least one of polyoxyethylene 20 sorbitan monooleate, and a proviso that if isobutyl magnolol is selected, then the sorbitan ester is poloxyethylene 20 sorbitan monooleate.

    Abstract translation: 一种组合物,其包含溶解的厚朴酚类似物和脱水山梨糖醇酯,所述溶解的厚朴酚类似物包含至少一种选自丙基木兰酚,异丙基木兰酚,丁基木兰酚和异丁基木兰酚的厚朴酚类似物。 这些增溶的类似物可用于个人护理,口腔护理和家庭护理组合物中,以提供抗细菌活性并降低促炎介质的表达。 如果选择异丙醇,那么脱水山梨糖醇酯是聚氧乙烯20山梨糖醇酐单油酸酯中的至少一种,并且条件是如果选择异丁基木兰酚,则脱水山梨糖醇酯是聚氧乙烯20失水山梨糖醇单油酸酯。

Patent Agency Ranking